Abstract | BACKGROUND/AIM: KT2 is a lysine/ tryptophan-rich peptide modified from Crocodylus siamensis Leucrocin I. In this study, we examined the cell toxicity, cellular uptake, anti-migration and anti-invasion activities of KT2 in A375.S2 human melanoma cells. MATERIALS AND METHODS: A375.S2 cells were treated with KT2 peptide and then we performed MTT assay, study of cellular uptake by a confocal microscope, wound healing assay, transwell migration/invasion assay, and evaluation of the expression of metastasis-associated proteins. RESULTS: KT2 can be internalized through the plasma membrane and can slightly alter cell morphology, decrease the percentage of viable cells and inhibit cell migration and invasion of A375.S2 cells in a dose-dependent manner. This peptide suppressed MMP-2 activity, as measured by gelatine zymography assay. The protein level of MMP-2 was decreased by KT2. KT2 also down-regulated metastasis pathway-related molecules, including FAK, RhoA, ROCK1, GRB2, SOS-1, p-JNK, p-c-Jun, PI3K, p-AKT (Thr308), p-AKT (Ser473), p-p38, MMP-9, NF-kB, and uPA. CONCLUSION: These results indicate that KT2 inhibits the migration and invasion of human melanoma cells by decreasing MMP-2 and MMP-9 expression through inhibition of FAK, uPA, MAPK, PI3K/AKT NF-kB, and RhoA-ROCK signalling pathways. These findings suggest that KT2 deserves further investigation as an anti-metastatic agent for human melanoma.
|
Authors | Pornsuda Maraming, Sompong Klaynongsruang, Patcharee Boonsiri, Shu-Fen Peng, Sakda Daduang, Prapenpuksiri Rungsa, Ratree Tavichakorntrakool, Jing-Gung Chung, Jureerut Daduang |
Journal | In vivo (Athens, Greece)
(In Vivo)
2021 Jan-Feb
Vol. 35
Issue 1
Pg. 215-227
ISSN: 1791-7549 [Electronic] Greece |
PMID | 33402468
(Publication Type: Journal Article)
|
Copyright | Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Chemical References |
- Tryptophan
- ROCK1 protein, human
- rho-Associated Kinases
- Matrix Metalloproteinase 2
- Lysine
|
Topics |
- Cell Line, Tumor
- Cell Movement
- Humans
- Lysine
- Matrix Metalloproteinase 2
(genetics)
- Melanoma
(drug therapy)
- Neoplasm Invasiveness
- Phosphatidylinositol 3-Kinases
(genetics)
- Tryptophan
- rho-Associated Kinases
|